Longtime Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics Post author:Sam Post published:December 3, 2017 Post category:BioPharma The COO of Seattle Genetics, Eric Dobmeier, is leaving the company to helm Silverback Therapeutics. Source: BioSpace You Might Also Like Bioverativ Appoints Executive Vice President, Research And Development April 9, 2017 Is There a Biotech Bubble Brewing in Boston? March 20, 2018 InVivo Therapeutics To Present At s 37th Annual Growth Conference August 7, 2017